Search

Author/Creator Mohapi, Lerato

11. Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV. (1st March 2022)

Authors:
Mohapi, Lerato; Pinedo, Yvett; Osiyemi, Olayemi; Supparatpinyo, Khuanchai; Ratanasuwan, Winai; Molina, Jean-Michel; Dagan, Ron; Tamms, Gretchen; Sterling, Tina; Zhang, Ying; Pedley, Alison; Hartzel, Jon; Kan, Yanqing; Hurtado, Kim; Musey, Luwy; Simon, Jakub K.; Buchwald, Ulrike K.
Journal:
AIDS
Issue:
Volume 36:Number 3(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

12. Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in adults living with HIV. (1st March 2022)

Authors:
Mohapi, Lerato; Pinedo, Yvett; Osiyemi, Olayemi; Supparatpinyo, Khuanchai; Ratanasuwan, Winai; Molina, Jean-Michel; Dagan, Ron; Tamms, Gretchen; Sterling, Tina; Zhang, Ying; Pedley, Alison; Hartzel, Jon; Kan, Yanqing; Hurtado, Kim; Musey, Luwy; Simon, Jakub K.; Buchwald, Ulrike K.
Other Names:
collaborator.
Journal:
AIDS
Issue:
Volume 36:Number 3(2022)
Page Start:
373
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

13. Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study. Issue 9 (September 2019)

Authors:
Grinsztejn, Beatriz; Hughes, Michael D; Ritz, Justin; Salata, Robert; Mugyenyi, Peter; Hogg, Evelyn; Wieclaw, Linda; Gross, Robert; Godfrey, Catherine; Cardoso, Sandra W; Bukuru, Aggrey; Makanga, Mumbi; Faesen, Sharlaa; Mave, Vidya; Wangari Ndege, Beatrice; Nerette Fontain, Sandy; Samaneka, Wadza...
Journal:
Lancet
Issue:
Volume 6:Issue 9(2019)
Page Start:
e588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

14. Third‐line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource‐limited settings: ACTG A5288 strategy trial. Issue 6 (15th June 2022)

Authors:
Avihingsanon, Anchalee; Hughes, Michael D.; Salata, Robert; Godfrey, Catherine; McCarthy, Caitlyn; Mugyenyi, Peter; Hogg, Evelyn; Gross, Robert; Cardoso, Sandra W.; Bukuru, Aggrey; Makanga, Mumbi; Badal‐aesen, Sharlaa; Mave, Vidya; Ndege, Beatrice Wangari; Fontain, Sandy Nerette; Samaneka, Wadzan...
Journal:
Journal of the International AIDS Society
Issue:
Volume 25:Issue 6(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

15. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study. (28th March 2019)

Authors:
Suryavanshi, Nishi; Murrill, Matthew; Gupta, Amita; Hughes, Michael; Hesseling, Anneke; Kim, Soyeon; Naini, Linda; Jones, Lynne; Smith, Betsy; Gupte, Nikhil; Dawson, Rodney; Mave, Vidya; Meshram, Sushant; Mendoza-Ticona, Alberto; Sanchez, Jorge; Kumarasamy, Nagalingeswaran; Comins, Kyla; Conradie...
Journal:
Clinical infectious diseases
Issue:
Volume 70:Number 3(2020)
Page Start:
436
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗